๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
Epithelial ovarian cancer is the most lethal gynecological malignancy in de...
Status
Unknown
Location
Tampere University Hospital
Start Date
2016-05
Trial ID
NCT02758652
This is a study focused on analyses of peripheral blood (tissue study). The...
Status
Active Not Recruiting
Location
IRCCS Azienda Ospedaliero - Universitaria di Bologna
Start Date
2024-10-01
Trial ID
NCT06730035
Treatments Being Tested
The purpose of this study is to determine the proportion of pancreatic pati...
Status
Terminated
Location
Stephenson Cancer Center
Start Date
2022-12-07
Trial ID
NCT05275075
Treatments Being Tested
Basic and clinical research is revealing that various noncoding and small R...
Status
Completed
Location
Weill Cornell Medicine
Start Date
2014-04
Trial ID
NCT02864329
MiRNAs are single-stranded small non-coding RNAs that act on specific mRNAs...
Status
Withdrawn
Location
Johns Hopkins at Green Spring Station
Start Date
2002-07
Trial ID
NCT01510054
Background: Extracellular RNAs (exRNAs) send genetic data from cell to cel...
Status
Completed
Location
Framingham Heart Study
Start Date
2017-07-17
Trial ID
NCT03225196
Background: The Framingham Heart Study (FHS) was initiated by the U.S Publ...
Status
Completed
Location
Framingham Heart Study
Start Date
2017-07-14
Trial ID
NCT03225183
Multiple biomarker development through validation of useful markers generat...
Status
Completed
Location
Severance Hospital, Yonsei University
Start Date
2016-09
Trial ID
NCT02807896
RATIONALE: Studying samples of blood, tissue, and bone marrow from patients...
Status
Completed
Location
Multiple Locations
Start Date
2012-02
Trial ID
NCT01511575
Treatments Being Tested
With around 3,400 cases per year in France, diffuse gliomas are the most co...
Status
Recruiting
Location
Arthur LECLERC
Start Date
2024-04-25
Trial ID
NCT06610851
Treatments Being Tested